S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Nippon Shinyaku Net Profit Falls to ¥25.8B Despite Revenue Growth

Nippon Shinyaku Co. Ltd. reported a decline in net profit for the first nine months of its fiscal year, even as the Japanese drugmaker saw its total revenue climb. For the period ending December 31, the company reported a net profit of ¥25.84 billion, down from the ¥28.55 billion recorded during the same timeframe a year earlier.

Nippon Shinyaku Net Profit Falls to ¥25.8B Despite Revenue Growth

The company’s financial results, reported under IFRS accounting standards, highlight a period of diverging performance. While total revenue rose to ¥127.14 billion from ¥121.32 billion, this top-line growth failed to translate into higher earnings. Operating profit saw a slight contraction, settling at ¥32.33 billion compared to ¥32.75 billion in the previous year.

Financial Performance Breakdown

Pretax figures followed a similar downward trend, reaching ¥33.23 billion against the prior year's ¥33.44 billion. The squeeze on margins resulted in diluted earnings per share falling to ¥383.50, down from ¥423.84 in the prior period, according to the company's financial statement.

The nine-month performance indicators for the Kyoto-based firm include:

  • Group revenue increased by approximately 4.8% to ¥127.14 billion.
    • Net profit attributable to the company fell by nearly 9.5% year-over-year.
    • Operating profit margins tightened slightly to approximately 25.4%.
The results suggest that while Nippon Shinyaku continues to expand its market reach, rising costs or shifts in product mix may be weighing on its overall profitability. The company did not immediately provide specific guidance regarding the factors behind the increased expenditure relative to revenue gains.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!